• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用κ-卡拉胶通过湿挤出/滚圆法制造的微丸的性质:工艺参数的影响

Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.

作者信息

Thommes Markus, Kleinebudde Peter

机构信息

Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University, Düsseldorf, Germany.

出版信息

AAPS PharmSciTech. 2007 Nov 9;8(4):E95. doi: 10.1208/pt0804095.

DOI:10.1208/pt0804095
PMID:18181555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2750681/
Abstract

The aim of this study was to systematically evaluate the pelletization process parameters of kappa-carrageenan-containing formulations. The study dealt with the effect of 4 process parameters--screw speed, number of die holes, friction plate speed, and spheronizer temperature--on the pellet properties of shape, size, size distribution, tensile strength, and drug release. These parameters were varied systematically in a 2(4) full factorial design. In addition, 4 drugs--phenacetin, chloramphenicol, dimenhydrinate, and lidocaine hydrochloride--were investigated under constant process conditions. The most spherical pellets were achieved in a high yield by using a large number of die holes and a high spheronizer speed. There was no relevant influence of the investigated process parameters on the size distribution, mechanical stability, and drug release. The poorly soluble drugs, phenacetin and chloramphenicol, resulted in pellets with adequate shape, size, and tensile strength and a fast drug release. The salts of dimenhydrinate and lidocaine affected pellet shape, mechanical stability, and the drug release properties using an aqueous solution of pH 3 as a granulation liquid. In the case of dimenhydrinate, this was attributed to the ionic interactions with kappa-carrageenan, resulting in a stable matrix during dissolution that did not disintegrate. The effect of lidocaine is comparable to the effect of sodium ions, which suppress the gelling of carrageenan, resulting in pellets with fast disintegration and drug release characteristics. The pellet properties are affected by the process parameters and the active pharmaceutical ingredient used.

摘要

本研究的目的是系统评估含κ-卡拉胶制剂的制粒工艺参数。该研究探讨了4个工艺参数——螺杆速度、模孔数量、摩擦板速度和滚圆机温度——对颗粒形状、尺寸、尺寸分布、拉伸强度和药物释放等颗粒性质的影响。这些参数在2(4)全因子设计中系统地变化。此外,在恒定工艺条件下研究了4种药物——非那西丁、氯霉素、茶苯海明和盐酸利多卡因。通过使用大量模孔和高滚圆机速度,以高产率获得了最接近球形的颗粒。所研究的工艺参数对尺寸分布、机械稳定性和药物释放没有相关影响。难溶性药物非那西丁和氯霉素制成的颗粒具有合适的形状、尺寸和拉伸强度,且药物释放迅速。茶苯海明和利多卡因的盐类,以pH 3的水溶液作为制粒液时,会影响颗粒形状、机械稳定性和药物释放性能。对于茶苯海明,这归因于与κ-卡拉胶的离子相互作用,导致溶解过程中形成稳定的基质且不会崩解。利多卡因的作用与钠离子的作用相当,钠离子会抑制卡拉胶的胶凝作用,导致颗粒具有快速崩解和药物释放特性。颗粒性质受工艺参数和所用活性药物成分的影响。

相似文献

1
Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.使用κ-卡拉胶通过湿挤出/滚圆法制造的微丸的性质:工艺参数的影响
AAPS PharmSciTech. 2007 Nov 9;8(4):E95. doi: 10.1208/pt0804095.
2
Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.使用κ-卡拉胶作为造粒助剂的湿挤出/滚圆工艺进行茶碱丸粒的多次批量生产。
Pharm Dev Technol. 2013 Feb;18(1):225-35. doi: 10.3109/10837450.2012.700935. Epub 2012 Jul 11.
3
Effect of drying on extruded pellets based on kappa-carrageenan.干燥对基于κ-卡拉胶的挤压颗粒的影响。
Eur J Pharm Sci. 2007 Jun;31(2):112-8. doi: 10.1016/j.ejps.2007.02.010. Epub 2007 Mar 6.
4
Influence of MCC II fraction and storage conditions on pellet properties.MCC II 级分和储存条件对颗粒性质的影响。
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1039-45. doi: 10.1016/j.ejpb.2013.07.001. Epub 2013 Jul 17.
5
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.κ-卡拉胶作为微晶纤维素在挤出/滚圆法中替代制粒助剂的应用。II. 药物和填充剂类型的影响。
Eur J Pharm Biopharm. 2006 May;63(1):68-75. doi: 10.1016/j.ejpb.2005.10.003. Epub 2005 Dec 1.
6
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.κ-卡拉胶作为微晶纤维素在挤出/滚圆造粒法中的替代制粒助剂的应用。I. 填料类型和比例的影响
Eur J Pharm Biopharm. 2006 May;63(1):59-67. doi: 10.1016/j.ejpb.2005.10.002. Epub 2005 Dec 2.
7
In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.通过挤出/滚圆法制备的肠溶包衣淀粉基微丸的体外和体内评价
Eur J Pharm Biopharm. 2008 Sep;70(1):302-12. doi: 10.1016/j.ejpb.2008.04.019. Epub 2008 Apr 29.
8
The influence of plate design on the properties of pellets produced by extrusion and spheronization.压片设计对挤出和滚圆生产的丸粒性能的影响。
Int J Pharm. 2012 Sep 15;434(1-2):175-82. doi: 10.1016/j.ijpharm.2012.05.050. Epub 2012 May 30.
9
The behavior of different carrageenans in pelletization by extrusion/spheronization.不同卡拉胶在挤出/滚圆制粒过程中的行为。
Pharm Dev Technol. 2008;13(1):27-35. doi: 10.1080/10837450701702537.
10
Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.通过无溶剂冷挤压获得的含脂质粘合剂的速释微丸。
Eur J Pharm Biopharm. 2009 Jan;71(1):138-44. doi: 10.1016/j.ejpb.2008.08.020. Epub 2008 Sep 5.

引用本文的文献

1
Carrageenan: Drug Delivery Systems and Other Biomedical Applications.卡拉胶:药物传递系统和其他生物医学应用。
Mar Drugs. 2020 Nov 23;18(11):583. doi: 10.3390/md18110583.
2
Quantification of mass transfer during spheronisation.球形化过程中的传质量化。
AAPS PharmSciTech. 2012 Jun;13(2):493-7. doi: 10.1208/s12249-012-9770-y. Epub 2012 Mar 14.

本文引用的文献

1
Effect of drying on extruded pellets based on kappa-carrageenan.干燥对基于κ-卡拉胶的挤压颗粒的影响。
Eur J Pharm Sci. 2007 Jun;31(2):112-8. doi: 10.1016/j.ejps.2007.02.010. Epub 2007 Mar 6.
2
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.κ-卡拉胶作为微晶纤维素在挤出/滚圆造粒法中的替代制粒助剂的应用。I. 填料类型和比例的影响
Eur J Pharm Biopharm. 2006 May;63(1):59-67. doi: 10.1016/j.ejpb.2005.10.002. Epub 2005 Dec 2.
3
Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.κ-卡拉胶作为微晶纤维素在挤出/滚圆法中替代制粒助剂的应用。II. 药物和填充剂类型的影响。
Eur J Pharm Biopharm. 2006 May;63(1):68-75. doi: 10.1016/j.ejpb.2005.10.003. Epub 2005 Dec 1.
4
PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC.聚环氧乙烷(PEO)和甲氧基聚乙二醇(MPEG)存在于不含微晶纤维素(MCC)的高载药量挤出滚圆微丸中。
Int J Pharm. 2006 Jan 3;307(1):66-76. doi: 10.1016/j.ijpharm.2005.09.021. Epub 2005 Oct 25.
5
Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.交联聚乙烯吡咯烷酮作为球形化助剂的功能:微晶纤维素的一种有前景的替代品。
Pharm Res. 2005 Aug;22(8):1387-98. doi: 10.1007/s11095-005-5279-3. Epub 2005 Aug 3.
6
Preliminary assessment of carrageenan as excipient for extrusion/spheronisation.角叉菜胶作为挤出/滚圆法辅料的初步评估
Eur J Pharm Biopharm. 2005 Jan;59(1):127-31. doi: 10.1016/j.ejpb.2004.05.007.
7
Comparison between a twin-screw extruder and a rotary ring die press. Part II: influence of process variables.双螺杆挤出机与旋转环模压机的比较。第二部分:工艺变量的影响。
Eur J Pharm Biopharm. 1998 Mar;45(2):173-9. doi: 10.1016/s0939-6411(97)00076-3.
8
Use of a power-consumption-controlled extruder in the development of pellet formulations.
J Pharm Sci. 1995 Oct;84(10):1259-64. doi: 10.1002/jps.2600841022.
9
Correlation of extrusion forces, raw materials and sphere characteristics.
J Pharm Pharmacol. 1992 Aug;44(8):676-8. doi: 10.1111/j.2042-7158.1992.tb05493.x.